Mankind Pharma

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,427.15",
    "chg": 51.75,
    "chgp": "2.18%",
    "dir": 1,
    "prev_price": "2,375.40",
    "mcapval": "99,904.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE634S01028",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "11.92 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Mankind Pharma Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-mankind-pharma-ltd-fallingrising-3982549",
        "imagepath": "",
        "date": "2026-05-09 03:57:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Consistent Outperformance Against Benchmarks</strong></p>\n<p>Mankind Pharma’s recent price trajectory has significantly outpaced the broader market indices. Over the past week, the stock has surged by 8.04%, compared to a modest 0.54% gain in the Sensex. This trend extends over longer periods as well, with the stock appreciating 18.85% in the last month while the Sensex declined by 0.30%. Year-to-date, Mankind Pharma has delivered a 10.51% return, contrasting sharply with the Sensex’s 9.26% loss. Even on a one-year horizon, the stock has managed a positive 1.11% return, outperforming the Sensex’s 3.74% decline. These figures underscore the company’s resilience and appeal amid broader market volatility.</p>\n<p><strong>Strong Technical Indicators and Market Momentum</strong></p>\n<p>On the day ..."
      },
      {
        "title": "When is the next results date for Mankind Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mankind-pharma-ltd-3982496",
        "imagepath": "",
        "date": "2026-05-08 23:17:29",
        "description": "The next results date for Mankind Pharma Ltd is scheduled for 19 May 2026...."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3977508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_mojoScore_3977508.png",
        "date": "2026-05-06 10:10:40",
        "description": "Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3962105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_mojoScore_3962105.png",
        "date": "2026-04-25 10:10:25",
        "description": "Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-3961223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_oi_spurts_by_underlying_3961223.png",
        "date": "2026-04-24 15:01:15",
        "description": "Mankind Pharma Ltd has witnessed a notable 16.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight price dip of 0.41% on 24 Apr 2026, the pharmaceutical mid-cap’s derivatives market shows increased volume and participation, reflecting complex directional bets amid broader sector and market trends."
      },
      {
        "title": "Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-significant-open-interest-surge-amid-mixed-market-signals-3961084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_oi_spurts_by_underlying_3961084.png",
        "date": "2026-04-24 14:00:56",
        "description": "Mankind Pharma Ltd has witnessed a notable 14.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price decline of 0.64% on 24 Apr 2026, the pharmaceutical mid-cap’s derivatives market reveals complex directional bets amid broader sector and index weakness."
      },
      {
        "title": "Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-significant-open-interest-surge-amid-mixed-market-signals-3960969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_oi_spurts_by_underlying_3960969.png",
        "date": "2026-04-24 13:00:41",
        "description": "Mankind Pharma Ltd has witnessed a notable 13.1% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight price dip of 0.25% on 24 Apr 2026, the pharmaceutical mid-cap continues to attract significant volume and delivery participation, reflecting complex directional bets amid broader sector and market weakness."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-3960884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_oi_spurts_by_underlying_3960884.png",
        "date": "2026-04-24 12:00:16",
        "description": "Mankind Pharma Ltd has witnessed a notable 13.44% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the surge in open interest alongside rising volumes suggests evolving directional bets within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amidst Strong Price Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amidst-strong-price-momentum-3959524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_oi_spurts_by_underlying_3959524.png",
        "date": "2026-04-23 15:01:09",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock has outperformed its sector peers, registering a 2.39% gain on 23 Apr 2026, supported by a 27.23% increase in open interest, reflecting growing bullish sentiment despite a recent downgrade in its Mojo Grade to Sell."
      }
    ],
    "total": 511,
    "sid": "1003845",
    "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Inter Alia Consider And Approve The Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended On March 31 2026 And Realignment Of Security Cover Provided In Respect Of Existi",
      "datetime": "07-May-2026",
      "details": "Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31 2026 and realignment of security cover provided in respect of existing Non-Convertible Debentures.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "06-May-2026",
      "details": "Please find enclosed herewith Annual Secretarial Compliance Report for the financial year ended on March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "22-Apr-2026",
      "details": "Please find attached intimation regarding Credit Ratings assigned by CARE Ratings Limited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "19 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Mankind Pharma Ltd falling/rising?

2026-05-09 03:57:21

Consistent Outperformance Against Benchmarks

Mankind Pharma’s recent price trajectory has significantly outpaced the broader market indices. Over the past week, the stock has surged by 8.04%, compared to a modest 0.54% gain in the Sensex. This trend extends over longer periods as well, with the stock appreciating 18.85% in the last month while the Sensex declined by 0.30%. Year-to-date, Mankind Pharma has delivered a 10.51% return, contrasting sharply with the Sensex’s 9.26% loss. Even on a one-year horizon, the stock has managed a positive 1.11% return, outperforming the Sensex’s 3.74% decline. These figures underscore the company’s resilience and appeal amid broader market volatility.

Strong Technical Indicators and Market Momentum

On the day ...

Read full news article

When is the next results date for Mankind Pharma Ltd?

2026-05-08 23:17:29

The next results date for Mankind Pharma Ltd is scheduled for 19 May 2026....

Read full news article

Mankind Pharma Ltd is Rated Sell

2026-05-06 10:10:40

Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Mankind Pharma Ltd is Rated Sell

2026-04-25 10:10:25

Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-24 15:01:15

Mankind Pharma Ltd has witnessed a notable 16.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight price dip of 0.41% on 24 Apr 2026, the pharmaceutical mid-cap’s derivatives market shows increased volume and participation, reflecting complex directional bets amid broader sector and market trends.

Read full news article

Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-04-24 14:00:56

Mankind Pharma Ltd has witnessed a notable 14.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price decline of 0.64% on 24 Apr 2026, the pharmaceutical mid-cap’s derivatives market reveals complex directional bets amid broader sector and index weakness.

Read full news article

Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-04-24 13:00:41

Mankind Pharma Ltd has witnessed a notable 13.1% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight price dip of 0.25% on 24 Apr 2026, the pharmaceutical mid-cap continues to attract significant volume and delivery participation, reflecting complex directional bets amid broader sector and market weakness.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-24 12:00:16

Mankind Pharma Ltd has witnessed a notable 13.44% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the surge in open interest alongside rising volumes suggests evolving directional bets within the Pharmaceuticals & Biotechnology sector.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amidst Strong Price Momentum

2026-04-23 15:01:09

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock has outperformed its sector peers, registering a 2.39% gain on 23 Apr 2026, supported by a 27.23% increase in open interest, reflecting growing bullish sentiment despite a recent downgrade in its Mojo Grade to Sell.

Read full news article

View All News